Abstract:
The invention provides a method for the detection of a polymorphism in OATPB in a human which method comprises determining the sequence of the human at one of the following positions: position (1113) of SEQ ID NO: 4 and/or position (312) of SEQ ID NO: 5. The polymorphism at position (1113) is presence of G and/or A and the polymorphism at position (312) is presence of Arg and/or Gln. The method for detection of a nucleic acid polymorphism is selected from amplification refractory mutation system and restriction fragment length polymorphism. The invention also provides use of the method to assess the pharmacogenetics of a drug transportable by OATB.
Abstract translation:本发明提供了一种用于检测人中OATPB多态性的方法,该方法包括在以下位置之一确定人的序列:SEQ ID NO:4的位置(1113)和/或SEQ ID NO:4的位置(312) SEQ ID NO:5。位置(1113)上的多态性是G和/或A的存在,位置(312)处的多态性是Arg和/或Gln的存在。 检测核酸多态性的方法选自扩增耐火突变体系和限制性片段长度多态性。 本发明还提供了评估OATB可运输药物的药物遗传学的方法的用途。
Abstract:
The invention provides a method for the detection of a polymorphism in OATPF in a human. The method for detection of a nucleic acid polymorphism is selected from amplification refractory mutation system and restriction fragment length polymorphism. The invention also provides use of the method to assess the pharmacogenetics of a drug transportable by OATF.
Abstract:
A mask system is provided to fit pre-adult patients, or patients having facial features that are very small or child-like, e.g., patients having dimensions in the lower 5%10% of the population. For example, the headgear and/or cushion are dimensioned to accommodate this range of patients.
Abstract:
A respiratory mask (10) having a cushion (40) with a side wass structure and a seal extending away from the side wall to define a trapezoidal aperture. The side wall of the cushion is removably attached to a frame (20) of the mask and head gear (80) is also removably attached (94) and to the frame.
Abstract:
The invention provides a method for the detection of a polymorphism in OATPB in a human which method comprises determining the sequence of the human at one of the following positions: position (1113) of SEQ ID NO: 4 and/or position (312) of SEQ ID NO: 5. The polymorphism at position (1113) is presence of G and/or A and the polymorphism at position (312) is presence of Arg and/or Gln. The method for detection of a nucleic acid polymorphism is selected from amplification refractory mutation system and restriction fragment length polymorphism. The invention also provides use of the method to assess the pharmacogenetics of a drug transportable by OATB.
Abstract translation:本发明提供了一种用于检测人中OATPB多态性的方法,该方法包括在以下位置之一确定人的序列:SEQ ID NO:4的位置(1113)和/或SEQ ID NO:4的位置(312) SEQ ID NO:5。位置(1113)上的多态性是G和/或A的存在,位置(312)处的多态性是Arg和/或Gln的存在。 检测核酸多态性的方法选自扩增耐火突变体系和限制性片段长度多态性。 本发明还提供了评估OATB可运输药物的药物遗传学的方法的用途。
Abstract:
A nasal assembly (600) for delivering breathable gas to a patient includes a frame (616) having an integrally formed first connector portion (618). A nozzle assembly (604) includes a gusset or base portion and a pair of nozzles. At least one inlet conduit (606) is structured to deliver breathable gas into the frame (616) and nozzle assembly (604) for breathing by the patient. A pair of second connector portions (20, 40, 614, 622, 636) are removably and rotatably connected to respective first connector portions (618) of the frame (616) and are in communication with respective inlet conduits (606), e.g., directly or via angle connectors (612). A headgear assembly (602) is removably connected to the pair of second connector portions (20, 40, 614, 622, 636) and/or the angle connectors (612) so as to maintain the frame (616) and the nozzle assembly (604) in a desired adjusted position on the patient's face.
Abstract:
A nasal assembly (600) for delivering breathable gas to a patient includes a frame (616) having an integrally formed first connector portion (618). A nozzle assembly (604) includes a gusset or base portion and a pair of nozzles. At least one inlet conduit (606) is structured to deliver breathable gas into the frame (616) and nozzle assembly (604) for breathing by the patient. A pair of second connector portions (20, 40, 614, 622, 636) are removably and rotatably connected to respective first connector portions (618) of the frame (616) and are in communication with respective inlet conduits (606), e.g., directly or via angle connectors (612). A headgear assembly (602) is removably connected to the pair of second connector portions (20, 40, 614, 622, 636) and/or the angle connectors (612) so as to maintain the frame (616) and the nozzle assembly (604) in a desired adjusted position on the patient's face.
Abstract:
A mask system is provided to fit pre-adult patients, or patients having facial features that are very small or child-like, e.g., patients having dimensions in the lower 5%10% of the population. For example, the headgear and/or cushion are dimensioned to accommodate this range of patients.